We narrowed to 14,278 results for: RON
-
Plasmid#145384PurposeYeast Expression plasmid for SARS-CoV-2 ORF3a proteinDepositorInsertSARS-CoV-2 ORF3a protein (ORF3a Severe acute respiratory syndrome coronavirus 2, Budding Yeast)
TagsCleavable thrombin;StrepIIExpressionYeastMutationSaccharomyces cerevisiae recode 1PromoterpTEF1Available SinceApril 29, 2020AvailabilityIndustry, Academic Institutions, and Nonprofits -
pGBW-m4046507
Plasmid#145385PurposeYeast Expression plasmid for SARS-CoV-2 ORF10 proteinDepositorInsertSARS-CoV-2 ORF10 protein (ORF10 Severe acute respiratory syndrome coronavirus 2, Budding Yeast)
TagsCleavable thrombin;6xHISExpressionYeastMutationSaccharomyces cerevisiae recode 1PromoterpTEF1Available SinceApril 29, 2020AvailabilityIndustry, Academic Institutions, and Nonprofits -
PCx35-pcDNA-S110A, S276A, S298ter
Plasmid#42927DepositorInsertConnexin 35
ExpressionMammalianMutationSer110 to Ala, Ser276 to Ala, and Ser298 to stop …PromoterCMVAvailable SinceMarch 26, 2013AvailabilityAcademic Institutions and Nonprofits only -
pAAV-hSyn-DIO-Cx35-M1-FLAG-T2A-mCherry
Plasmid#255638PurposeEncodes floxed (DIO) M. americana Cx35, codon optimized for mouse expression and c-terminally fused FLAG tag, T2A self-cleaving peptide and mCherry. Mutation of K221E. hSyn promoter.DepositorInsertCx35
UseAAVTagsFLAG-T2A-mCherryMutationK221EPromoterhSynAvailable SinceMay 26, 2026AvailabilityAcademic Institutions and Nonprofits only -
pSA092 CCT3_IVS13-Cas9-BFP
Plasmid#249142PurposeOverexpression of SpCas9-BFP with CCT3 IVS13 intron in 5' UTR and blasticidin resistance gene. Contains Cp36 recombination site.DepositorInsertCCT3_IVS13-Cas9-TagBFP (CCT3 Human, S. pyogenes Cas9, synthetic)
UseCRISPR; Cp36 donor dnaExpressionMammalianMutationCCT3 IVS13 intronPromoterEF1aAvailable SinceJan. 8, 2026AvailabilityAcademic Institutions and Nonprofits only -
pSA074 Cas9-BFP/HBB_IVS2/BFP
Plasmid#249135PurposeOverexpression of SpCas9-BFP with HBB IVS2 intron within BFP coding sequence and blasticidin resistance gene. Contains Cp36 recombination site.DepositorInsertCas9-TagBFP/HBB_IVS2/TagBFP (HBB Human, S. pyogenes Cas9, synthetic)
UseCRISPR; Cp36 donor dnaExpressionMammalianMutationHBB IVS2 intronPromoterEF1aAvailable SinceJan. 7, 2026AvailabilityAcademic Institutions and Nonprofits only -
pSA076 Cas9/HBB_IVS2/Cas9-BFP
Plasmid#249137PurposeOverexpression of SpCas9-BFP with HBB IVS2 intron within Cas9 coding sequence and blasticidin resistance gene. Contains Cp36 recombination site.DepositorInsertCas9/HBB_IVS2/Cas9-TagBFP (HBB Human, S. pyogenes Cas9, synthetic)
UseCRISPR; Cp36 donor dnaExpressionMammalianMutationHBB IVS2 intronPromoterEF1aAvailable SinceJan. 7, 2026AvailabilityAcademic Institutions and Nonprofits only -
pHis-TEV-Nsp15-E266Q
Plasmid#218803PurposeE. coli plasmid (T7lac promoter) for full-length, SARS CoV-2 Nsp15-E266Q (uridine-specific nidoviral endoribonuclease, expression-optimized gene) with N-terminal TEV protease cleavable His6-tagDepositorInsertNsp15-E266Q (N Severe acute respiratory syndrome coronavirus 2)
TagsTEV protease cleavable His6-tagExpressionBacterialMutationE266Q (G to C)Available SinceMay 27, 2025AvailabilityAcademic Institutions and Nonprofits only -
pHis-TEV-Nsp15-V66L
Plasmid#219524PurposeE. coli plasmid (T7lac promoter) for full-length, SARS CoV-2 Nsp15-V66L (uridine-specific nidoviral endoribonuclease, expression-optimized gene) with N-terminal TEV protease cleavable His6-tagDepositorInsertNsp15-V66L (N Severe acute respiratory syndrome coronavirus 2)
TagsTEV protease cleavable His6-tagExpressionBacterialMutationV66L (G to C)Available SinceMay 27, 2025AvailabilityIndustry, Academic Institutions, and Nonprofits -
pHis-TEV-Nsp15-A81V
Plasmid#219525PurposeE. coli plasmid (T7lac promoter) for full-length, SARS CoV-2 Nsp15-A81V (uridine-specific nidoviral endoribonuclease, expression-optimized gene) with N-terminal TEV protease cleavable His6-tagDepositorInsertNsp15-A81V (N Severe acute respiratory syndrome coronavirus 2)
TagsTEV protease cleavable His6-tagExpressionBacterialMutationA81V (C to T)Available SinceMay 27, 2025AvailabilityIndustry, Academic Institutions, and Nonprofits